InfuSystem (INFU) Competitors $6.10 -0.02 (-0.33%) Closing price 05/20/2025 04:00 PM EasternExtended Trading$6.08 -0.02 (-0.31%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock INFU vs. SMLR, TMCI, CLPT, NNOX, STIM, SMTI, SNWV, ZIMV, TCMD, and NYXHShould you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include Semler Scientific (SMLR), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. InfuSystem vs. Semler Scientific Treace Medical Concepts ClearPoint Neuro Nano-X Imaging Neuronetics Sanara MedTech SANUWAVE Health ZimVie Tactile Systems Technology Nyxoah InfuSystem (NYSE:INFU) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Which has more risk and volatility, INFU or SMLR? InfuSystem has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Which has higher valuation & earnings, INFU or SMLR? Semler Scientific has lower revenue, but higher earnings than InfuSystem. Semler Scientific is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$137.58M0.93$870K$0.1443.57Semler Scientific$56.29M8.30$20.58M-$2.61-16.05 Does the media refer more to INFU or SMLR? In the previous week, InfuSystem had 1 more articles in the media than Semler Scientific. MarketBeat recorded 8 mentions for InfuSystem and 7 mentions for Semler Scientific. InfuSystem's average media sentiment score of 1.30 beat Semler Scientific's score of 0.56 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Semler Scientific 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of INFU or SMLR? 71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 11.4% of InfuSystem shares are owned by insiders. Comparatively, 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community prefer INFU or SMLR? InfuSystem received 9 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 100.00% of users gave InfuSystem an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote. CompanyUnderperformOutperformInfuSystemOutperform Votes11100.00% Underperform VotesNo VotesSemler ScientificOutperform Votes266.67% Underperform Votes133.33% Is INFU or SMLR more profitable? Semler Scientific has a net margin of 72.65% compared to InfuSystem's net margin of 1.12%. Semler Scientific's return on equity of 50.77% beat InfuSystem's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Semler Scientific 72.65%50.77%47.04% Do analysts prefer INFU or SMLR? InfuSystem currently has a consensus target price of $13.00, indicating a potential upside of 113.11%. Semler Scientific has a consensus target price of $71.00, indicating a potential upside of 69.53%. Given InfuSystem's stronger consensus rating and higher probable upside, equities research analysts plainly believe InfuSystem is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryInfuSystem beats Semler Scientific on 12 of the 19 factors compared between the two stocks. Get InfuSystem News Delivered to You Automatically Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INFU vs. The Competition Export to ExcelMetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$128.20M$4.55B$5.43B$19.70BDividend YieldN/A43.65%5.22%3.84%P/E Ratio101.6829.8726.8335.13Price / Sales0.9371.05393.9834.12Price / Cash12.7951.0838.2517.51Price / Book2.476.346.874.78Net Income$870,000.00$67.64M$3.22B$1.02B7 Day Performance6.46%21.94%6.76%1.62%1 Month Performance24.24%26.54%13.66%13.00%1 Year PerformanceN/A22.75%18.27%5.59% InfuSystem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INFUInfuSystem2.4951 of 5 stars$6.10-0.3%$13.00+113.1%N/A$128.20M$137.58M101.68410News CoveragePositive NewsSMLRSemler Scientific2.5881 of 5 stars$43.27+5.8%$71.00+64.1%+78.4%$482.55M$56.29M8.81120Gap UpHigh Trading VolumeTMCITreace Medical Concepts2.3247 of 5 stars$6.73+0.1%$10.16+50.9%+35.4%$423.25M$210.82M-6.80250Trending NewsCLPTClearPoint Neuro1.7425 of 5 stars$13.12-0.5%$25.00+90.5%+108.6%$368.90M$31.39M-19.01110Positive NewsGap UpNNOXNano-X Imaging1.46 of 5 stars$5.48-2.1%$12.00+119.0%-43.7%$316.63M$11.28M-6.45190News CoverageUpcoming EarningsGap UpSTIMNeuronetics1.9408 of 5 stars$4.29+1.7%$5.50+28.2%+69.6%$282.37M$89.45M-3.49180SMTISanara MedTech1.8016 of 5 stars$31.18-1.0%$49.50+58.8%-4.6%$277.13M$86.67M-31.4960Earnings ReportAnalyst RevisionSNWVSANUWAVE HealthN/A$29.58-8.4%N/AN/A$253.09M$36.19M-6.4940ZIMVZimVie2.2692 of 5 stars$8.75-2.9%$16.33+86.7%-47.9%$243.66M$443.55M-0.672,700Positive NewsGap UpTCMDTactile Systems Technology3.4181 of 5 stars$10.40flat$16.00+53.8%-23.8%$241.78M$293.16M14.86980NYXHNyxoah2.9488 of 5 stars$6.79+7.9%$14.50+113.5%-23.0%$231.27M$4.52M-3.63110Earnings ReportHigh Trading Volume Related Companies and Tools Related Companies SMLR Competitors TMCI Competitors CLPT Competitors NNOX Competitors STIM Competitors SMTI Competitors SNWV Competitors ZIMV Competitors TCMD Competitors NYXH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INFU) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INFU Stock Free INFU Stock Alerts